Clinical research and bioanalytical scientist with over twelve years of continuous laboratory practice across four countries, Nigeria, the United Arab Emirates, and the United States, spanning regulated drug-safety testing, clinical trial operations, molecular biology, and diagnostic laboratory leadership. Currently a Safety Testing Medical Technologist at Labcorp Clinical Laboratory Services (Drug Development), where my analyses inform go/no-go decisions on investigational compounds and have supported two Investigational New Drug (IND) submissions. His work sits at the regulatory core of drug development: assay design and validation, method verification, quality-control adjudication, and audit-ready documentation under CLIA, CAP, GLP, GCP, GMP, ISO and FDA frameworks. Author or co-author of sixteen peer-reviewed publications in cancer metabolism, bioanalysis, AI-enabled diagnostics and health-data governance, and my contribution to global drug-safety and COVID-19 clinical trial infrastructure has been the subject of feature coverage in two national newspapers.